Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Science (New York, N.Y.)
|
February 3, 2022
A highly virulent variant of HIV-1 circulating in the Netherlands
Chris Wymant, Daniela Bezemer, François Blanquart, et al.
Plos Pathogens
|
October 6, 2023
Correction: Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias
Helen R Fryer, Tanya Golubchik, Matthew Hall, et al.
Nature
|
February 21, 2024
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
Mahan Ghafari, Matthew Hall, Tanya Golubchik, et al.
Plos Pathogens
|
August 14, 2023
Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias
Helen R Fryer, Tanya Golubchik, Matthew Hall, et al.
Virus Evolution
|
December 10, 2025
The genetic architecture of HIV-1 virulence
François Blanquart, Chris Wymant, Matthew Hall, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda
Mélodie Monod, Andrea Brizzi, Ronald M Galiwango, et al.
Nature Microbiology
|
December 5, 2023
Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda
Mélodie Monod, Andrea Brizzi, Ronald M Galiwango, et al.
Science (New York, N.Y.)
|
March 10, 2021
SARS-CoV-2 within-host diversity and transmission
Katrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
BMC Bioinformatics
|
August 15, 2025
HIV-phyloTSI: subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data
Tanya Golubchik, Lucie Abeler-Dörner, Matthew Hall, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Science (New York, N.Y.)
|
February 3, 2022
A highly virulent variant of HIV-1 circulating in the Netherlands
Chris Wymant, Daniela Bezemer, François Blanquart, et al.
Plos Pathogens
|
October 6, 2023
Correction: Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias
Helen R Fryer, Tanya Golubchik, Matthew Hall, et al.
Nature
|
February 21, 2024
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
Mahan Ghafari, Matthew Hall, Tanya Golubchik, et al.
Plos Pathogens
|
August 14, 2023
Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias
Helen R Fryer, Tanya Golubchik, Matthew Hall, et al.
Virus Evolution
|
December 10, 2025
The genetic architecture of HIV-1 virulence
François Blanquart, Chris Wymant, Matthew Hall, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda
Mélodie Monod, Andrea Brizzi, Ronald M Galiwango, et al.
Nature Microbiology
|
December 5, 2023
Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda
Mélodie Monod, Andrea Brizzi, Ronald M Galiwango, et al.
Science (New York, N.Y.)
|
March 10, 2021
SARS-CoV-2 within-host diversity and transmission
Katrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
BMC Bioinformatics
|
August 15, 2025
HIV-phyloTSI: subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data
Tanya Golubchik, Lucie Abeler-Dörner, Matthew Hall, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Page
of 8